1890P Switch-maintenance therapy with nivolumab in TKI-sensitive patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis for PD-L1 status of a randomized phase II study (NIVOSWITCH)
| Autor: | Darr, C., Ivanyi, P., Wirth, M., Zschäbitz, S., Schostak, M., Mueller, L., Steiner, T., Welslau, M.K., Schuett, P., Lorch, A., Rafiyan, M-R., Hellmis, E., Meiler, J., Kretz, T., Loidl, W.C., Floercken, A., Stöhr, C.G., Eckstein, M., Hartmann, A., Grünwald, V. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S1017-S1017 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|